Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous Leukemia
- 30 November 2006
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 8 (5), 604-612
- https://doi.org/10.2353/jmoldx.2006.060089
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Wild-type blocking polymerase chain reaction for detection of single nucleotide minority mutations from clinical specimensOncogene, 2005
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaBlood, 2004
- Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal Of Cancer, 2004
- Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatographyLeukemia, 2004
- KIT Mutations Are Common in Testicular SeminomasThe American Journal of Pathology, 2004
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in SizeThe American Journal of Pathology, 2002
- Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive MalignanciesJournal of Clinical Oncology, 2002
- Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosisExperimental Hematology, 2000
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.JCI Insight, 1993